Products
Online Inquiry
Asperulosidic acid
Cat. No.:
OB0225WX-2044
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Asperulosidic acid is an iridoid glycoside that inhibits the production of inflammatory mediators and cytokines by suppressing the MAPK and NF-kappaB signaling cascades.
Synonym:
ASPA; 25368-11-0; (1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid; Asperuloside acid; Asperulosidic acid(1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid
CAS No.:
25368-11-0
Compound CID:
11968867
Formula:
C18H24O12
Formula Weight:
432.38
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Asperulosidic acid is used in metabolic research as an iridoid glycoside to study its anti-obesity effects and its ability to modulate fatty acid oxidation and lipid accumulation.
Library Information
Target:
NF-κB; ERK
Receptor:
NF-κB; ERK
Pathways:
NF-κB; MAPK
Plate Number:
AOCL-27
Plate Location:
b7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
65 mg/mL; 150.32 mM
